000 01752 a2200505 4500
005 20250514074514.0
264 0 _c20040709
008 200407s 0 0 eng d
022 _a1099-498X
024 7 _a10.1002/jgm.387
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLiu, Yongqing
245 0 0 _aDendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
_h[electronic resource]
260 _bThe journal of gene medicine
_cAug 2003
300 _a668-80 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenoviridae
_xgenetics
650 0 4 _aAdjuvants, Immunologic
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aCancer Vaccines
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Movement
_xphysiology
650 0 4 _aChemokines
_xmetabolism
650 0 4 _aCytokines
_xmetabolism
650 0 4 _aDendritic Cells
_ximmunology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmune System
_xphysiology
650 0 4 _aKiller Cells, Natural
_ximmunology
650 0 4 _aMembrane Proteins
_xgenetics
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Inbred C57BL
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aSurvival Rate
650 0 4 _aT-Lymphocytes
_xcytology
650 0 4 _aT-Lymphocytes, Cytotoxic
_ximmunology
650 0 4 _aTransgenes
700 1 _aHuang, Hui
700 1 _aChen, Zhuang
700 1 _aZong, Li
700 1 _aXiang, Jim
773 0 _tThe journal of gene medicine
_gvol. 5
_gno. 8
_gp. 668-80
856 4 0 _uhttps://doi.org/10.1002/jgm.387
_zAvailable from publisher's website
999 _c12673824
_d12673824